The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Neurocrine Biosciences, Inc. (NASDAQ: NBIX) closed at $149.59 up 0.91% from its previous closing price of $148.24. In other words, the price has increased by $0.91 from its previous closing price. On the day, 0.66 million shares were traded. NBIX stock price reached its highest trading level at $149.91 during the session, while it also had its lowest trading level at $145.73.
Ratios:
For a deeper understanding of Neurocrine Biosciences, Inc.’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 14.54 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 30.54. For the most recent quarter (mrq), Quick Ratio is recorded 4.08 and its Current Ratio is at 4.19. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on April 24, 2024, Upgraded its rating to Overweight and sets its target price to $170 from $140 previously.
On December 12, 2023, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $136.Deutsche Bank initiated its Buy rating on December 12, 2023, with a $136 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 15 ’24 when RASTETTER WILLIAM H sold 14,250 shares for $146.69 per share. The transaction valued at 2,090,332 led to the insider holds 37,491 shares of the business.
LYONS GARY A sold 11,570 shares of NBIX for $1,740,450 on Aug 13 ’24. The Director now owns 119,047 shares after completing the transaction at $150.43 per share. On Aug 13 ’24, another insider, ABERNETHY MATT, who serves as the Chief Financial Officer of the company, sold 14,100 shares for $150.38 each. As a result, the insider received 2,120,347 and left with 31,528 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NBIX now has a Market Capitalization of 15104999424 and an Enterprise Value of 14357737472. As of this moment, Neurocrine’s Price-to-Earnings (P/E) ratio for their current fiscal year is 45.19, and their Forward P/E ratio for the next fiscal year is 22.15. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.38. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.13 while its Price-to-Book (P/B) ratio in mrq is 6.02. Its current Enterprise Value per Revenue stands at 6.774 whereas that against EBITDA is 25.216.
Stock Price History:
Over the past 52 weeks, NBIX has reached a high of $157.98, while it has fallen to a 52-week low of $103.63. The 50-Day Moving Average of the stock is 5.16%, while the 200-Day Moving Average is calculated to be 11.35%.
Shares Statistics:
For the past three months, NBIX has traded an average of 801.80K shares per day and 699580 over the past ten days. A total of 98.70M shares are outstanding, with a floating share count of 98.57M. Insiders hold about 2.39% of the company’s shares, while institutions hold 93.14% stake in the company. Shares short for NBIX as of 1722384000 were 2671781 with a Short Ratio of 3.33, compared to 1719532800 on 2817799. Therefore, it implies a Short% of Shares Outstanding of 2671781 and a Short% of Float of 3.1.
